The role of cava-pulmonary (Glenn) anastomosis in the palliative treatment of congenital heart disease

D. Di Carlo, W. G. Williams, R. M. Freedom, G. A. Trusler, R. D. Rowe

Research output: Contribution to journalArticle

Abstract

The value of the cava-pulmonary anastomosis (Glenn procedure) was assessed by reviewing the entire experience with this procedure in 83 children at The Hospital for Sick Children, Toronto, from 1961 to 1980. The over-all operative mortality rate was 9.6%, but only 2% in the second half of the series. The average follow-up is 9.4 years per patient. The late mortality rate has been 20%. By actuarial analysis, 84% of survivors were alive 9 years after operation; 54% had adequate palliation and 46% had required further operation. Long-term palliation was significantly better when the anastomosis was performed after 5 years of age. A previous arterial pulmonary artery shunt had no effect on either patient or shunt survival. Patients with tricuspid atresia had a better long-term survival rate than, but similar shunt survival to, those children with transposition, single ventricle, or miscellaneous cardiac anomalies. Angiography in 36 survivors showed patent shunts in 35 and no arteriovenous fistulas. Clinical status was not related to superior vena caval pressure or angiographic findings, indicating that Glenn shunt failure is a functional problem. The procedure is most useful for patients over 5 years of age who have complex heart disease not amenable to total repair. It is also an appropriate initial procedure in young patients over 18 months of age for whom direct atrium-pulmonary artery anastomosis is proposed as the future definitive treatment.

Original languageEnglish
Pages (from-to)437-442
Number of pages6
JournalJournal of Thoracic and Cardiovascular Surgery
Volume83
Issue number3
Publication statusPublished - 1982

Fingerprint

Palliative Care
Heart Diseases
Lung
Pulmonary Artery
Survivors
Actuarial Analysis
Tricuspid Atresia
Venae Cavae
Survival
Mortality
Arteriovenous Fistula
Angiography
Survival Rate
Pressure
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

The role of cava-pulmonary (Glenn) anastomosis in the palliative treatment of congenital heart disease. / Di Carlo, D.; Williams, W. G.; Freedom, R. M.; Trusler, G. A.; Rowe, R. D.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 83, No. 3, 1982, p. 437-442.

Research output: Contribution to journalArticle

Di Carlo, D. ; Williams, W. G. ; Freedom, R. M. ; Trusler, G. A. ; Rowe, R. D. / The role of cava-pulmonary (Glenn) anastomosis in the palliative treatment of congenital heart disease. In: Journal of Thoracic and Cardiovascular Surgery. 1982 ; Vol. 83, No. 3. pp. 437-442.
@article{42de68836868437b8019fa51616ba810,
title = "The role of cava-pulmonary (Glenn) anastomosis in the palliative treatment of congenital heart disease",
abstract = "The value of the cava-pulmonary anastomosis (Glenn procedure) was assessed by reviewing the entire experience with this procedure in 83 children at The Hospital for Sick Children, Toronto, from 1961 to 1980. The over-all operative mortality rate was 9.6{\%}, but only 2{\%} in the second half of the series. The average follow-up is 9.4 years per patient. The late mortality rate has been 20{\%}. By actuarial analysis, 84{\%} of survivors were alive 9 years after operation; 54{\%} had adequate palliation and 46{\%} had required further operation. Long-term palliation was significantly better when the anastomosis was performed after 5 years of age. A previous arterial pulmonary artery shunt had no effect on either patient or shunt survival. Patients with tricuspid atresia had a better long-term survival rate than, but similar shunt survival to, those children with transposition, single ventricle, or miscellaneous cardiac anomalies. Angiography in 36 survivors showed patent shunts in 35 and no arteriovenous fistulas. Clinical status was not related to superior vena caval pressure or angiographic findings, indicating that Glenn shunt failure is a functional problem. The procedure is most useful for patients over 5 years of age who have complex heart disease not amenable to total repair. It is also an appropriate initial procedure in young patients over 18 months of age for whom direct atrium-pulmonary artery anastomosis is proposed as the future definitive treatment.",
author = "{Di Carlo}, D. and Williams, {W. G.} and Freedom, {R. M.} and Trusler, {G. A.} and Rowe, {R. D.}",
year = "1982",
language = "English",
volume = "83",
pages = "437--442",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - The role of cava-pulmonary (Glenn) anastomosis in the palliative treatment of congenital heart disease

AU - Di Carlo, D.

AU - Williams, W. G.

AU - Freedom, R. M.

AU - Trusler, G. A.

AU - Rowe, R. D.

PY - 1982

Y1 - 1982

N2 - The value of the cava-pulmonary anastomosis (Glenn procedure) was assessed by reviewing the entire experience with this procedure in 83 children at The Hospital for Sick Children, Toronto, from 1961 to 1980. The over-all operative mortality rate was 9.6%, but only 2% in the second half of the series. The average follow-up is 9.4 years per patient. The late mortality rate has been 20%. By actuarial analysis, 84% of survivors were alive 9 years after operation; 54% had adequate palliation and 46% had required further operation. Long-term palliation was significantly better when the anastomosis was performed after 5 years of age. A previous arterial pulmonary artery shunt had no effect on either patient or shunt survival. Patients with tricuspid atresia had a better long-term survival rate than, but similar shunt survival to, those children with transposition, single ventricle, or miscellaneous cardiac anomalies. Angiography in 36 survivors showed patent shunts in 35 and no arteriovenous fistulas. Clinical status was not related to superior vena caval pressure or angiographic findings, indicating that Glenn shunt failure is a functional problem. The procedure is most useful for patients over 5 years of age who have complex heart disease not amenable to total repair. It is also an appropriate initial procedure in young patients over 18 months of age for whom direct atrium-pulmonary artery anastomosis is proposed as the future definitive treatment.

AB - The value of the cava-pulmonary anastomosis (Glenn procedure) was assessed by reviewing the entire experience with this procedure in 83 children at The Hospital for Sick Children, Toronto, from 1961 to 1980. The over-all operative mortality rate was 9.6%, but only 2% in the second half of the series. The average follow-up is 9.4 years per patient. The late mortality rate has been 20%. By actuarial analysis, 84% of survivors were alive 9 years after operation; 54% had adequate palliation and 46% had required further operation. Long-term palliation was significantly better when the anastomosis was performed after 5 years of age. A previous arterial pulmonary artery shunt had no effect on either patient or shunt survival. Patients with tricuspid atresia had a better long-term survival rate than, but similar shunt survival to, those children with transposition, single ventricle, or miscellaneous cardiac anomalies. Angiography in 36 survivors showed patent shunts in 35 and no arteriovenous fistulas. Clinical status was not related to superior vena caval pressure or angiographic findings, indicating that Glenn shunt failure is a functional problem. The procedure is most useful for patients over 5 years of age who have complex heart disease not amenable to total repair. It is also an appropriate initial procedure in young patients over 18 months of age for whom direct atrium-pulmonary artery anastomosis is proposed as the future definitive treatment.

UR - http://www.scopus.com/inward/record.url?scp=0020078213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020078213&partnerID=8YFLogxK

M3 - Article

C2 - 6174832

AN - SCOPUS:0020078213

VL - 83

SP - 437

EP - 442

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 3

ER -